Cleo Diagnostics Ratios and Metrics

Market cap in millions AUD. Fiscal year is July - June.

Millions AUD. Fiscal year is Jul - Jun.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023
Period Ending	Mar '26 Mar 16, 2026	Jun '25 Jun 30, 2025	Jun '24 Jun 30, 2024	Jun '23 Jun 30, 2023
Market Capitalization	67	50	44	-
Market Cap Growth	15.97%	14.71%	-	-
Enterprise Value	58	43	34	-
Last Close Price	0.49	0.39	0.34	-
PS Ratio	26.17	59.30	207.25	-
PB Ratio	7.60	8.59	4.65	-
P/TBV Ratio	7.90	9.15	4.86	-
EV/Sales Ratio	22.49	50.65	159.30	-
Debt / Equity Ratio	-	-	-	-1.70
Net Debt / Equity Ratio	-1.07	-1.11	-1.00	-1.44
Net Debt / EBITDA Ratio	2.47	1.61	2.62	-0.82
Net Debt / FCF Ratio	3.74	2.22	4.61	-1.88
Asset Turnover	0.29	0.10	0.04	-
Quick Ratio	8.39	5.93	19.40	0.13
Current Ratio	8.46	5.94	19.41	0.29
Return on Equity (ROE)	-49.57%	-52.53%	-88.99%	-
Return on Assets (ROA)	-27.12%	-30.35%	-41.55%	-
Return on Capital Employed (ROCE)	-43.90%	-70.00%	-38.80%	180.20%
Earnings Yield	-6.01%	-7.98%	-8.60%	-
FCF Yield	-3.76%	-5.81%	-4.65%	-
Buyback Yield / Dilution	-10.54%	-9.53%	-346.76%	-

Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.